Teleflex Inc - Company Profile
Powered by 
All the sales intelligence you need on Teleflex Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Teleflex Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Teleflex Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Teleflex Inc (Teleflex) is a medical device company. It primarily designs, develops, manufactures, and supplies single-use medical devices in critical care and surgical applications. Its major products include vascular access devices, interventional catheters, anesthesia equipment, and respiratory care products. The company also offers technical support and repair of products, clinical support services, partial shipments and special orders. Teleflex markets its products to hospitals, healthcare providers, distributors, and original equipment manufacturers through brands Arrow, Deknatel, QuikClot, LMA, Pilling, Rusch, UroLift, and Weck, among others. The company markets and sells its products through direct sales and distributors. It operates manufacturing facilities in the Czech Republic, Malaysia, Mexico, and the US. Teleflex is headquartered in Wayne, Pennsylvania, the US.
Headquarters
United States of America
Address
550 E Swedesford Rd, Suite 400, Wayne, Pennsylvania, 19087
Website
www.teleflex.com
Telephone
1 610 2256800
No of Employees
15,500
Industry
Medical Equipment
Ticker Symbol & Exchange
TFX (NYSE)
Revenue (2024)
$2.0B
17.2%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-1399.8%
(2024 vs 2023)
Market Cap*
$5.6B
Net Profit Margin (2024)
XYZ
-1,208.5%
(2024 vs 2023)
* As of and is in US$
Teleflex Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Vascular Access: | Engineering | Arrow |
| Central Venous Catheters (CVC) | Regulatory Affairs | LMA |
| Peripherally Inserted Central Catheters (PICC) | Prototyping | Rusch |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In December, the company signed an agreement to sell Teleflex Medical OEM to Montagu and Kohlberg for US$1.5 billion. |
| 2025 | Contracts/Agreements | In December, the company signed an agreement to sell Acute Care, Interventional Urology and OEM businesses to Intersurgical Ltd and Montagu and Kohlberg for US$2.03 billion. |
| 2025 | New Products/Services | In August, the company introduced Barrigel rectal spacer in Japan. |
Competitor Comparison
| Key Parameters | Teleflex Inc | Abbott Laboratories | Medtronic Plc | Boston Scientific Corp | Merit Medical Systems Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Ireland | United States of America | United States of America |
| City | Wayne | Abbott Park | Dublin | Marlborough | South Jordan |
| State/Province | Pennsylvania | Illinois | - | Massachusetts | Utah |
| No. of Employees | 15,500 | 115,000 | 95,000 | 59,000 | 7,500 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John R. Deren | Executive Vice President; Chief Financial Officer | Senior Management | 2025 | 58 |
| Timothy F. Duffy | Chief Information Officer; Vice President | Senior Management | 2012 | - |
| Howard Cyr | Chief Compliance Officer; Corporate Vice President | Senior Management | 2018 | - |
| Cameron P. Hicks | Chief Human Resources Officer; Corporate Vice President | Senior Management | 2021 | 61 |
| Jason Weidman | President; Chief Executive Officer - Interim; Director | Executive Board | 2026 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer